Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan

Nafamostat mesylate (NM) is a synthetic serine protease inhibitor that can be used as an anticoagulant during blood purification in critically ill patients, as well as a treatment for disseminated intravascular coagulation. Although NM has been reported to reduce the risk of bleeding during blood pu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med
Asıl Yazarlar: Kamijo, Hiroshi, Mochizuki, Katsunori, Nakamura, Yuta, Mori, Kotaro, Ichikawa, Michitaro, Nitta, Kenichi, Imamura, Hiroshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464767/
https://ncbi.nlm.nih.gov/pubmed/32823637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082629
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller